Atlas Trials

Gruppo Italiano MEsotelioma

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Gruppo Italiano MEsotelioma

RecordFirmDate
A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma (NCT00551252)Gruppo Italiano MEsotelioma2008-01-01

Track Gruppo Italiano MEsotelioma automatically

Every clearance here is in the API, with alerts when new ones post.